<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="pmc-domain-id">2786</journal-id><journal-id journal-id-type="pmc-domain">medicine</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431730</article-id><article-id pub-id-type="pmcid-ver">PMC12431730.1</article-id><article-id pub-id-type="pmcaid">12431730</article-id><article-id pub-id-type="pmcaiid">12431730</article-id><article-id pub-id-type="pmid">39252303</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000039393</article-id><article-id pub-id-type="publisher-id">MD-D-24-05506</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>6700</subject></subj-group><subj-group><subject>Research Article</subject><subject>Observational Study</subject></subj-group></article-categories><title-group><article-title>Association between self-reported sleep apnea and biomarkers of liver injury: Evidence from National Health and Nutrition Examination Survey</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="YB">Yi-Bin</given-names></name><degrees>MD</degrees><email>598623241@qq.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8093-6831</contrib-id><name name-style="western"><surname>Huang</surname><given-names initials="ZW">Zhi-Wei</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">b</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="XJ">Xue-Jun</given-names></name><degrees>MD</degrees><email>846599952@qq.com</email><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Luo</surname><given-names initials="JM">Jia-Min</given-names></name><degrees>MD</degrees><email>ljm812326709@qq.com</email><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="LD">Li-Da</given-names></name><degrees>MD</degrees><email>361328175@qq.com</email><xref rid="aff4" ref-type="aff">d</xref></contrib><aff id="aff1"><label>a</label> Health Management Center, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People&#8217;s Republic of China</aff><aff id="aff2"><label>b</label> Department of Otolaryngology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian Province, People&#8217;s Republic of China</aff><aff id="aff3"><label>c</label> Department of Laboratory Medicine, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People&#8217;s Republic of China</aff><aff id="aff4"><label>d</label> Department of Respiratory and Critical Care Medicine, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People&#8217;s Republic of China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Zhi-Wei Huang, Department of Otolaryngology, Quanzhou First Hospital Affiliated to Fujian Medical University, Dongjie Road, Licheng District, Quanzhou, Fujian Province 362000, People&#8217;s Republic of China (e-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="659573747@qq.com">659573747@qq.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>06</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>06</day><month>9</month><year>2024</year></pub-date><volume>103</volume><issue>36</issue><issue-id pub-id-type="pmc-issue-id">470382</issue-id><elocation-id>e39393</elocation-id><history><date date-type="received"><day>20</day><month>5</month><year>2024</year></date><date date-type="received"><day>17</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>01</day><month>8</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>06</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="medi-103-e39393.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="medi-103-e39393.pdf"/><abstract><p>The community population based studies on the relationship between obstructive sleep apnea and liver injury are limited. The study aimed to clarify the association between sleep apnea (SA) and liver injury by using the data in The National Health and Nutrition Examination Survey. SA was assessed by the sleep questionnaire and liver injury was evaluated by liver function test, hepatic steatosis index, and fibrosis-4. Weighted multivariable linear regression was performed to examine the association between SA and liver injury. Subgroup analyses and sensitivity analysis were also conducted. A total of 19,362 eligible participants were included in the study. After adjusting for confounders, the presence of SA was significantly associated with increased levels of lnALT, lnAST/alanine aminotransferase, lnGGT, and lnHSI (all <italic toggle="yes">P</italic> values&#8197;&lt;&#8197;.05), but not with lnFIB-4 (<italic toggle="yes">P</italic>&#8197;&gt;&#8197;.05). There is a dose&#8211;response relationship between the severity of SA and increased levels of lnALT, lnGGT, and decreased levels of lnAST/alanine aminotransferase (test for trend, all <italic toggle="yes">P</italic> values&#8197;&lt;&#8197;.05). Subgroup analyses revealed that the positive association between SA and liver function, liver steatosis showed a tendency to exist in nonobese, younger, non-Hispanic Black, and male populations. Sensitive analysis showed the relationship between SA and liver injury was stable. Self-reported SA was independently associated with elevated liver enzymes and liver steatosis among US population. The association was more pronounced among nonobese, younger, non-Hispanic Black, and male populations.</p></abstract><kwd-group><kwd>cross-sectional survey</kwd><kwd>liver injury</kwd><kwd>NHANES</kwd><kwd>nonalcoholic fatty liver disease</kwd><kwd>sleep apnea</kwd></kwd-group><funding-group><award-group id="ID0E1YAE125606"><funding-source>Young People Training Project from Fujian Province Health Bureau</funding-source><award-id>2022GGA053</award-id><principal-award-recipient>Li-Da Chen</principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>Obstructive sleep apnea (OSA) is a highly prevalent condition linked to numerous adverse health outcomes, including cardiovascular problems,<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> cognitive impairment,<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> metabolic disorder,<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> and an increased risk of traffic accidents.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> The prevalence of OSA in the overall population ranges from 9% to 38%.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> Clinically, the OSA patients exhibit a recurring pattern of upper airway obstruction and frequent awakenings during sleep, resulting in chronic intermittent hypoxia (CIH), sleep fragmentation, daytime sleepiness, and even hypercapnia. The most common risk factors of OSA are age, male gender, and obesity.<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> Race difference represents another risk factor for OSA.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup></p><p>Over the last 2 decades, there has been a growing interest in the correlation between OSA and liver injury, particularly nonalcoholic fatty liver disease (NAFLD).<sup>[<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>]</sup> We previously included 85 patients with NAFLD and found a significant independent correlation between OSA-related hypoxia and the biochemical markers of liver injury.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> A recent study analyzing 183 obesity patients demonstrated that OSA exacerbated NAFLD and increased the risk of nonalcoholic steatohepatitis in obese patients based on liver histopathological evidence.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> However, most of studies exploring this issue were performed in a clinically based setting and limited by small sample size. The community population based studies on the relationship between OSA and liver injury are lacking.</p><p>Thus, we designed this study to clarify the association between sleep apnea (SA) and liver injury by using the large community-based data in The National Health and Nutrition Examination Survey (NHANES). Furthermore, the subgroup analyses were subsequently conducted to explore this association according to age, body mass index (BMI), gender, and race.</p></sec><sec sec-type="methods"><title>2. Methods</title><sec><title>2.1. Study population</title><p>The NHANES is a complex, nationally representative, stratified, multistage probabilistic health survey of the US population conducted every 2 years since 1999 by the Centers for Disease Control and Prevention. The NHANES study was approved by the Ethical Review Board of the National Center for Health Statistics, and all participants provided informed written consent. NHANES database are freely and publicly available. The data from 2005 to 2008 and 2015 to 2020 NHANES database with complete questionnaires data on sleep disorders (snoring, gasping, and stopping breathing while sleeping) and complete liver function test were extracted in the current study. Both outcomes and exposure data were derived from all available survey cycles within this timeframe. Sleep questionnaire SLQ040 was not adopted in the 2009 to 2014 NHANES survey, leading us to exclude these specific data sets. The exclusion criteria for this study are outlined below: 1. excess alcohol intake (defined as &gt;3 standard drinks per day in males; or &gt;2 standard drinks per day in females)<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup>; 2. pregnant women; 3. virus hepatitis (positive hepatitis B surface antigen or hepatitis C virus RNA); 4. age &lt;16 years old; 5. missing data on exposures and outcomes.</p></sec><sec><title>2.2. Outcome assessment</title><p>The liver injury was evaluated by the aspects including liver function, liver steatosis, and liver fibrosis. Liver function was determined by measuring serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), AST/ALT, total bilirubin, albumin, total protein (TP), and alkaline phosphatase, gamma glutamyl transpeptidase. The hepatic steatosis index (HSI) was applied to quantify the degree of liver steatosis. Liver fibrosis was estimated using the fibrosis-4 (FIB-4) index. The following formulas were used for calculating HSI and FIB-4. HSI&#8197;=&#8197;8&#8197;&#215;&#8197;ALT/AST ratio&#8197;+&#8197;BMI (kg/m<sup>2</sup>) (+2, if diabetes mellitus; +2, if female). FIB-4&#8197;=&#8197;(age [years]&#8197;&#215;&#8197;AST [U/L])/(platelet [10<sup>9</sup>/L]&#8197;&#215;&#8197;(ALT [U/L])<sup>1/2</sup>).</p></sec><sec><title>2.3. Exposure assessment</title><p>The presence and severity of SA relied solely on self-reported symptoms and were not corroborated by polysomnography. SA was judged by the individual&#8217;s responses to the questionnaire on sleep disorders (how often did you snort, gasp, or stop breathing while asleep?).<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> The presence and severity of SA were based on the following answer: rarely (1&#8211;2 nights per week), occasionally (3&#8211;4 nights per week), and frequently (5 or more nights per week). The answer of never was classified as absent SA.</p></sec><sec><title>2.4. Covariates assessment</title><p>The covariates included in the models were selected a priori, in accordance with prior empirical evidence linking OSA and liver injury.<sup>[<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup> Gender, age, BMI, race, family income-to-poverty ratio (PIR), smoking status, drink status, hypertension, diabetes, and coronary heart disease (CHD) were taken into account as potential confounding factors. Race was divided into 5 distinct categories, which included Mexican American, other Hispanic, non-Hispanic White, non-Hispanic Black, and other racial groups. BMI was calculated by weight (kg)/height (m<sup>2</sup>). The presence of hypertension, diabetes, and CHD was established through self-reported physician diagnoses, indicating a history of these conditions. Smoking status was classified into 2 categories: smokers and nonsmokers, based on the response to the following question: &#8220;Have you smoked at least 100 cigarettes in your lifetime?&#8221; As for drinking status: nondrinker, did not have more than 12 drinks in entire life (data from 2005&#8211;2008 and 2015&#8211;2016) or did not have 1 drink of any kind of alcohol (data from 2017&#8211;2020); excess drinker: had more than 2 drinks per day for females or more than 3 drinks per day for males; the rest was classified as drinker. The excess drinkers were excluded from this study.</p></sec><sec><title>2.5. Statistical analysis</title><p>All analyses applied Mobile Examination Center sample weights to account for oversampling, nonresponse, noncoverage, and to permit nationally representative estimates. The continuous variables were reported as the weighted mean with standard deviation, and the categorical variables were shown as counts with weighted percentages. To compare the differences between the 4 groups, Chi-square test was used for categorical variables, weighted linear regression was used for continuous variables. Weighted multivariate linear regression analyses were applied to explore the independent associations between SA and outcome variables. Tests for linear trends were also performed. A log transformation was employed for skewed outcome data. In addition, we divided subjects into subgroups based on BMI, age, gender, and race, and then investigated the relationship between SA and liver injury within each subgroup. In sensitive analysis, the missing values of confounders were managed using random forest interpolation with the &#8220;missForest&#8221; R package. The missing data of covariate data are summarized in Table S1, Supplemental Digital Content, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/MD/N417" ext-link-type="uri">http://links.lww.com/MD/N417</ext-link>. Weighted multivariate linear regression analyses adjusting the confounding variables including imputed data were further performed to examine the robust result. All analyses were performed in R software (version 4.3.0; R Foundation for Statistical Computing) and GraphPad Prism 8 (GraphPad Software Inc.). All tests were conducted with a two-tailed approach. <italic toggle="yes">P</italic> values &lt;.05 were regarded as statistically significant.</p></sec></sec><sec sec-type="results"><title>3. Results</title><sec><title>3.1. Baseline characteristics in subjects stratified by SA severity</title><p>A total of 19,362 eligible participants were included in the final analysis. Detailed information about the inclusion and exclusion is provided in Figure <xref rid="F1" ref-type="fig">1</xref>. Baseline characteristics and liver injury parameters stratified by SA severity are summarized in Table <xref rid="T1" ref-type="table">1</xref>. Among the participants, 15,220 were classified as no SA, 2038 as mild SA, 1130 as moderate SA, and 974 as severe SA. Subjects with SA were older, were more likely to be male, had higher BMI and prevalence of smoking, drinking, hypertension, diabetes, CHD. There were no statistically significant differences observed among the 4 groups in terms of PIR or the prevalence of race. Regarding the issue of liver injury, as the severity of SA increased, there was a notable and significant rise in the levels of ALT, AST, alkaline phosphatase, gamma glutamyl transpeptidase, and HSI score, as well as the FIB-4 score. Conversely, total protein and albumin exhibited a decrease with SA severity.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics and liver injury parameters in subjects stratified by SA severity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Overall</th><th align="center" rowspan="1" colspan="1">Absent</th><th align="center" rowspan="1" colspan="1">Mild</th><th align="center" rowspan="1" colspan="1">Moderate</th><th align="center" rowspan="1" colspan="1">Severe</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of subjects</td><td align="center" rowspan="1" colspan="1">19,362</td><td align="center" rowspan="1" colspan="1">15,220</td><td align="center" rowspan="1" colspan="1">2038</td><td align="center" rowspan="1" colspan="1">1130</td><td align="center" rowspan="1" colspan="1">974</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Male, number (%)</td><td align="center" rowspan="1" colspan="1">9320 (47.3%)</td><td align="center" rowspan="1" colspan="1">7009 (44.9%)</td><td align="center" rowspan="1" colspan="1">1093 (52.6%)</td><td align="center" rowspan="1" colspan="1">648 (60.1%)</td><td align="center" rowspan="1" colspan="1">570 (57.5%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Female, number (%)</td><td align="center" rowspan="1" colspan="1">10,042 (52.7%)</td><td align="center" rowspan="1" colspan="1">8211 (55.1%)</td><td align="center" rowspan="1" colspan="1">945 (47.4%)</td><td align="center" rowspan="1" colspan="1">482 (39.9%)</td><td align="center" rowspan="1" colspan="1">404 (42.5%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age, years</td><td align="center" rowspan="1" colspan="1">47.01&#8197;&#177;&#8197;18.43</td><td align="center" rowspan="1" colspan="1">46.10&#8197;&#177;&#8197;18.84</td><td align="center" rowspan="1" colspan="1">48.91&#8197;&#177;&#8197;17.13</td><td align="center" rowspan="1" colspan="1">51.84&#8197;&#177;&#8197;16.32</td><td align="center" rowspan="1" colspan="1">51.56&#8197;&#177;&#8197;14.84</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">28.75&#8197;&#177;&#8197;6.92</td><td align="center" rowspan="1" colspan="1">28.10&#8197;&#177;&#8197;6.63</td><td align="center" rowspan="1" colspan="1">30.20&#8197;&#177;&#8197;7.27</td><td align="center" rowspan="1" colspan="1">31.05&#8197;&#177;&#8197;7.39</td><td align="center" rowspan="1" colspan="1">32.98&#8197;&#177;&#8197;7.44</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Race</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">.560</td></tr><tr><td align="left" rowspan="1" colspan="1">Mexican American, number (%)</td><td align="center" rowspan="1" colspan="1">3034 (7.7%)</td><td align="center" rowspan="1" colspan="1">2442 (7.8%)</td><td align="center" rowspan="1" colspan="1">296 (8.1%)</td><td align="center" rowspan="1" colspan="1">163 (7.8%)</td><td align="center" rowspan="1" colspan="1">133 (6.5%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Other Hispanic, number (%)</td><td align="center" rowspan="1" colspan="1">1834 (5.6%)</td><td align="center" rowspan="1" colspan="1">1402 (5.5%)</td><td align="center" rowspan="1" colspan="1">217 (6.2%)</td><td align="center" rowspan="1" colspan="1">110 (4.9%)</td><td align="center" rowspan="1" colspan="1">105 (6.0%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Non-Hispanic White, number (%)</td><td align="center" rowspan="1" colspan="1">7606 (67.2%)</td><td align="center" rowspan="1" colspan="1">5920 (67.1%)</td><td align="center" rowspan="1" colspan="1">809 (66.8%)</td><td align="center" rowspan="1" colspan="1">450 (66.6%)</td><td align="center" rowspan="1" colspan="1">427 (70.3%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Non-Hispanic Black, number (%)</td><td align="center" rowspan="1" colspan="1">4574 (11.3%)</td><td align="center" rowspan="1" colspan="1">3614 (11.3%)</td><td align="center" rowspan="1" colspan="1">481 (11.1%)</td><td align="center" rowspan="1" colspan="1">268 (11.8%)</td><td align="center" rowspan="1" colspan="1">211 (9.9%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Other race, number (%)</td><td align="center" rowspan="1" colspan="1">2314 (8.2%)</td><td align="center" rowspan="1" colspan="1">1842 (8.3%)</td><td align="center" rowspan="1" colspan="1">235 (7.8%)</td><td align="center" rowspan="1" colspan="1">139 (9.0%)</td><td align="center" rowspan="1" colspan="1">98 (7.3%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PIR</td><td align="center" rowspan="1" colspan="1">3.13&#8197;&#177;&#8197;1.63</td><td align="center" rowspan="1" colspan="1">3.13&#8197;&#177;&#8197;1.63</td><td align="center" rowspan="1" colspan="1">3.14&#8197;&#177;&#8197;1.62</td><td align="center" rowspan="1" colspan="1">3.20&#8197;&#177;&#8197;1.61</td><td align="center" rowspan="1" colspan="1">3.09&#8197;&#177;&#8197;1.59</td><td align="center" rowspan="1" colspan="1">.937</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Yes, number (%)</td><td align="center" rowspan="1" colspan="1">6756 (40.3%)</td><td align="center" rowspan="1" colspan="1">4973 (38.7%)</td><td align="center" rowspan="1" colspan="1">808 (42.5%)</td><td align="center" rowspan="1" colspan="1">484 (45.7%)</td><td align="center" rowspan="1" colspan="1">491 (52.8%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No, number (%)</td><td align="center" rowspan="1" colspan="1">10,448 (59.7%)</td><td align="center" rowspan="1" colspan="1">8270 (61.3%)</td><td align="center" rowspan="1" colspan="1">1111 (57.5%)</td><td align="center" rowspan="1" colspan="1">612 (54.3%)</td><td align="center" rowspan="1" colspan="1">455 (47.2%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Drinking</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Yes, number (%)</td><td align="center" rowspan="1" colspan="1">13,127 (86.7%)</td><td align="center" rowspan="1" colspan="1">9895 (85.6%)</td><td align="center" rowspan="1" colspan="1">1552 (89.3%)</td><td align="center" rowspan="1" colspan="1">895 (91.2%)</td><td align="center" rowspan="1" colspan="1">785 (91.0%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No, number (%)</td><td align="center" rowspan="1" colspan="1">2636 (13.3%)</td><td align="center" rowspan="1" colspan="1">2175 (14.4%)</td><td align="center" rowspan="1" colspan="1">237 (10.7%)</td><td align="center" rowspan="1" colspan="1">120 (8.8%)</td><td align="center" rowspan="1" colspan="1">104 (9.0%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Yes, number (%)</td><td align="center" rowspan="1" colspan="1">6393 (30.4%)</td><td align="center" rowspan="1" colspan="1">4562 (27.7%)</td><td align="center" rowspan="1" colspan="1">796 (36.0%)</td><td align="center" rowspan="1" colspan="1">520 (40.0%)</td><td align="center" rowspan="1" colspan="1">515 (48.7%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No, number (%)</td><td align="center" rowspan="1" colspan="1">12,947 (69.6%)</td><td align="center" rowspan="1" colspan="1">10,641 (72.3%)</td><td align="center" rowspan="1" colspan="1">1240 (64.0%)</td><td align="center" rowspan="1" colspan="1">607 (60.0%)</td><td align="center" rowspan="1" colspan="1">459 (51.3%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Yes, number (%)</td><td align="center" rowspan="1" colspan="1">2459 (9.9%)</td><td align="center" rowspan="1" colspan="1">1685 (8.7%)</td><td align="center" rowspan="1" colspan="1">316 (12.5%)</td><td align="center" rowspan="1" colspan="1">233 (12.9%)</td><td align="center" rowspan="1" colspan="1">225 (18.9%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No, number (%)</td><td align="center" rowspan="1" colspan="1">16,903 (90.1%)</td><td align="center" rowspan="1" colspan="1">13,535 (91.3%)</td><td align="center" rowspan="1" colspan="1">1722 (87.5%)</td><td align="center" rowspan="1" colspan="1">897 (87.1%)</td><td align="center" rowspan="1" colspan="1">749 (81.1%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CHD</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Yes, number (%)</td><td align="center" rowspan="1" colspan="1">802 (4.1%)</td><td align="center" rowspan="1" colspan="1">540 (3.6%)</td><td align="center" rowspan="1" colspan="1">103 (4.4%)</td><td align="center" rowspan="1" colspan="1">78 (6.0%)</td><td align="center" rowspan="1" colspan="1">81 (7.3%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No, number (%)</td><td align="center" rowspan="1" colspan="1">15,874 (95.9%</td><td align="center" rowspan="1" colspan="1">12,250 (96.4%)</td><td align="center" rowspan="1" colspan="1">1768 (95.6%)</td><td align="center" rowspan="1" colspan="1">1002 (94.0%)</td><td align="center" rowspan="1" colspan="1">854 (92.7%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ALT (U/L)</td><td align="center" rowspan="1" colspan="1">23.72&#8197;&#177;&#8197;16.77</td><td align="center" rowspan="1" colspan="1">23.08&#8197;&#177;&#8197;15.75</td><td align="center" rowspan="1" colspan="1">25.26&#8197;&#177;&#8197;21.65</td><td align="center" rowspan="1" colspan="1">26.38&#8197;&#177;&#8197;17.99</td><td align="center" rowspan="1" colspan="1">27.21&#8197;&#177;&#8197;17.71</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">AST (U/L)</td><td align="center" rowspan="1" colspan="1">23.98&#8197;&#177;&#8197;12.55</td><td align="center" rowspan="1" colspan="1">23.79&#8197;&#177;&#8197;12.59</td><td align="center" rowspan="1" colspan="1">24.43&#8197;&#177;&#8197;12.93</td><td align="center" rowspan="1" colspan="1">24.77&#8197;&#177;&#8197;11.70</td><td align="center" rowspan="1" colspan="1">25.08&#8197;&#177;&#8197;11.87</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">AST/ALT</td><td align="center" rowspan="1" colspan="1">1.13&#8197;&#177;&#8197;0.35</td><td align="center" rowspan="1" colspan="1">1.15&#8197;&#177;&#8197;0.36</td><td align="center" rowspan="1" colspan="1">1.08&#8197;&#177;&#8197;0.34</td><td align="center" rowspan="1" colspan="1">1.06&#8197;&#177;&#8197;0.35</td><td align="center" rowspan="1" colspan="1">1.02&#8197;&#177;&#8197;0.30</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">AKP (U/L)</td><td align="center" rowspan="1" colspan="1">71.08&#8197;&#177;&#8197;25.41</td><td align="center" rowspan="1" colspan="1">70.88&#8197;&#177;&#8197;25.63</td><td align="center" rowspan="1" colspan="1">71.18&#8197;&#177;&#8197;23.48</td><td align="center" rowspan="1" colspan="1">71.85&#8197;&#177;&#8197;25.57</td><td align="center" rowspan="1" colspan="1">73.02&#8197;&#177;&#8197;25.57</td><td align="center" rowspan="1" colspan="1">.019</td></tr><tr><td align="left" rowspan="1" colspan="1">TBIL (&#956;mol/L)</td><td align="center" rowspan="1" colspan="1">10.84&#8197;&#177;&#8197;5.79</td><td align="center" rowspan="1" colspan="1">10.91&#8197;&#177;&#8197;5.86</td><td align="center" rowspan="1" colspan="1">10.41&#8197;&#177;&#8197;5.63</td><td align="center" rowspan="1" colspan="1">10.85&#8197;&#177;&#8197;5.40</td><td align="center" rowspan="1" colspan="1">10.65&#8197;&#177;&#8197;5.38</td><td align="center" rowspan="1" colspan="1">.084</td></tr><tr><td align="left" rowspan="1" colspan="1">TP (g/dL)</td><td align="center" rowspan="1" colspan="1">7.11&#8197;&#177;&#8197;0.44</td><td align="center" rowspan="1" colspan="1">7.12&#8197;&#177;&#8197;0.44</td><td align="center" rowspan="1" colspan="1">7.10&#8197;&#177;&#8197;0.43</td><td align="center" rowspan="1" colspan="1">7.08&#8197;&#177;&#8197;0.43</td><td align="center" rowspan="1" colspan="1">7.08&#8197;&#177;&#8197;0.43</td><td align="center" rowspan="1" colspan="1">.001</td></tr><tr><td align="left" rowspan="1" colspan="1">ALB (g/dL)</td><td align="center" rowspan="1" colspan="1">4.25&#8197;&#177;&#8197;0.34</td><td align="center" rowspan="1" colspan="1">4.26&#8197;&#177;&#8197;0.34</td><td align="center" rowspan="1" colspan="1">4.25&#8197;&#177;&#8197;0.35</td><td align="center" rowspan="1" colspan="1">4.20&#8197;&#177;&#8197;0.33</td><td align="center" rowspan="1" colspan="1">4.17&#8197;&#177;&#8197;0.33</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">GGT (U/L)</td><td align="center" rowspan="1" colspan="1">25.96&#8197;&#177;&#8197;34.13</td><td align="center" rowspan="1" colspan="1">24.62&#8197;&#177;&#8197;30.80</td><td align="center" rowspan="1" colspan="1">27.57&#8197;&#177;&#8197;30.93</td><td align="center" rowspan="1" colspan="1">33.68&#8197;&#177;&#8197;63.55</td><td align="center" rowspan="1" colspan="1">34.30&#8197;&#177;&#8197;39.06</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">his</td><td align="center" rowspan="1" colspan="1">1.03&#8197;&#177;&#8197;0.79</td><td align="center" rowspan="1" colspan="1">1.01&#8197;&#177;&#8197;0.72</td><td align="center" rowspan="1" colspan="1">1.09&#8197;&#177;&#8197;0.77</td><td align="center" rowspan="1" colspan="1">1.22&#8197;&#177;&#8197;1.58</td><td align="center" rowspan="1" colspan="1">1.07&#8197;&#177;&#8197;0.56</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">FIB-4</td><td align="center" rowspan="1" colspan="1">37.77&#8197;&#177;&#8197;8.13</td><td align="center" rowspan="1" colspan="1">37.01&#8197;&#177;&#8197;7.83</td><td align="center" rowspan="1" colspan="1">39.53&#8197;&#177;&#8197;8.38</td><td align="center" rowspan="1" colspan="1">40.40&#8197;&#177;&#8197;8.58</td><td align="center" rowspan="1" colspan="1">42.72&#8197;&#177;&#8197;8.64</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>All means and SDs for continuous variables and percentages for categorical variables were weighted, with the exception of the number of participants.</p></fn><fn fn-type="other"><p>AKP = alkaline phosphatase, ALB = albumin, ALT = alanine aminotransferase, AST = aspartate aminotransferase, BMI = body mass index, CHD = coronary heart disease, FIB-4 = fibrosis-4, GGT = gamma glutamyl transpeptidase, HSI = hepatic steatosis index, PIR = family income-to-poverty ratio, SA = sleep apnea, TBIL = total bilirubin, TP = total protein.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>The flow chart of selection process.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="medi-103-e39393-g001.jpg"/></fig></sec><sec><title>3.2. Association between SA and liver injury</title><p>Table <xref rid="T2" ref-type="table">2</xref> displays the results of the association between SA and liver injury based on weighted multivariate linear regression. After adjusting for age, gender, race, BMI, PIR, smoking, drinking, hypertension, diabetes, CHD, the presence of SA was significantly associated with lnALT, lnAST/ALT, lnGGT, and lnHSI (all <italic toggle="yes">P</italic> values&#8197;&lt;&#8197;.05). In addition, the dose&#8211;response relationship between the severity of SA and liver injury was also explored. There is a dose&#8211;response relationship between the severity of SA and increased levels of lnALT, lnGGT, decreased level of lnAST/ALT (test for trend, all <italic toggle="yes">P</italic> values&#8197;&lt;&#8197;.05). Despite a trend of dose-response relationship was found between SA severity and increased lnHSI, the result did not reach statistically significant differences (test for trend, <italic toggle="yes">P</italic>&#8197;=&#8197;.087).</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Associations between SA and liver injury based on weighted multivariate linear regression.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="2">Outcomes</th><th align="center" rowspan="1" colspan="1">SA status</th><th align="center" colspan="4" rowspan="1">SA severity</th></tr><tr><th align="center" rowspan="1" colspan="1">SA</th><th align="center" rowspan="1" colspan="1">Rarely</th><th align="center" rowspan="1" colspan="1">Moderately</th><th align="center" rowspan="1" colspan="1">Frequently</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value for trend</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">LnALT</td><td align="center" rowspan="1" colspan="1">Adjusted <italic toggle="yes">&#946;</italic> (95% CI)</td><td align="center" rowspan="1" colspan="1">0.033 (0.008, 0.057)</td><td align="center" rowspan="1" colspan="1">0.031 (&#8208;0.000, 0.0628)</td><td align="center" rowspan="1" colspan="1">0.024 (&#8208;0.019, 0.067)</td><td align="center" rowspan="1" colspan="1">0.044 (0.009, 0.080)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">0.052</td><td align="center" rowspan="1" colspan="1">0.265</td><td align="center" rowspan="1" colspan="1">0.015</td><td align="center" rowspan="1" colspan="1">.041</td></tr><tr><td align="left" rowspan="2" colspan="1">LnAST</td><td align="center" rowspan="1" colspan="1">Adjusted <italic toggle="yes">&#946;</italic> (95% CI)</td><td align="center" rowspan="1" colspan="1">0.009 (&#8208;0.007, 0.026)</td><td align="center" rowspan="1" colspan="1">0.010 (&#8208;0.011, 0.031)</td><td align="center" rowspan="1" colspan="1">0.006 (&#8208;0.024, 0.035)</td><td align="center" rowspan="1" colspan="1">0.013 (&#8208;0.022, 0.047)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.254</td><td align="center" rowspan="1" colspan="1">.363</td><td align="center" rowspan="1" colspan="1">.707</td><td align="center" rowspan="1" colspan="1">.474</td><td align="center" rowspan="1" colspan="1">.542</td></tr><tr><td align="left" rowspan="2" colspan="1">LnAST/ALT</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">&#8208;0.023 (&#8208;0.039, &#8208;0.007)</td><td align="center" rowspan="1" colspan="1">&#8208;0.021 (&#8208;0.045, 0.002)</td><td align="center" rowspan="1" colspan="1">&#8208;0.019 (&#8208;0.042, 0.004)</td><td align="center" rowspan="1" colspan="1">&#8208;0.032 (&#8208;0.055, &#8208;0.009)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.004</td><td align="center" rowspan="1" colspan="1">.078</td><td align="center" rowspan="1" colspan="1">.109</td><td align="center" rowspan="1" colspan="1">.007</td><td align="center" rowspan="1" colspan="1">.020</td></tr><tr><td align="left" rowspan="2" colspan="1">lnGGT</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">0.058 (0.026, 0.090)</td><td align="center" rowspan="1" colspan="1">0.021 (&#8208;0.021, 0.063)</td><td align="center" rowspan="1" colspan="1">0.078 (0.019, 0.136)</td><td align="center" rowspan="1" colspan="1">0.112 (0.055, 0.170)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">.322</td><td align="center" rowspan="1" colspan="1">.010</td><td align="center" rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="2" colspan="1">LnAKP</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">-0.008 (-0.020, 0.004)</td><td align="center" rowspan="1" colspan="1">-0.003 (-0.019, 0.011)</td><td align="center" rowspan="1" colspan="1">-0.010 (-0.035, 0.014)</td><td align="center" rowspan="1" colspan="1">-0.013 (-0.038, 0.011)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.184</td><td align="center" rowspan="1" colspan="1">.607</td><td align="center" rowspan="1" colspan="1">.408</td><td align="center" rowspan="1" colspan="1">.276</td><td align="center" rowspan="1" colspan="1">.223</td></tr><tr><td align="left" rowspan="2" colspan="1">LnTP</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">-0.001 (-0.004, 0.001)</td><td align="center" rowspan="1" colspan="1">-0.001 (-0.005, 0.003)</td><td align="center" rowspan="1" colspan="1">-0.003 (-0.008, 0.002)</td><td align="center" rowspan="1" colspan="1">-0.000 (-0.005, 0.004)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.317</td><td align="center" rowspan="1" colspan="1">.577</td><td align="center" rowspan="1" colspan="1">.197</td><td align="center" rowspan="1" colspan="1">.869</td><td align="center" rowspan="1" colspan="1">.654</td></tr><tr><td align="left" rowspan="2" colspan="1">LnALB</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">&#8208;0.000 (&#8208;0.004, 0.004)</td><td align="center" rowspan="1" colspan="1">0.004 (&#8208;0.001, 0.009)</td><td align="center" rowspan="1" colspan="1">&#8208;0.005 (&#8208;0.012, 0.002)</td><td align="center" rowspan="1" colspan="1">&#8208;0.003 (&#8208;0.010, 0.004)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.944</td><td align="center" rowspan="1" colspan="1">.142</td><td align="center" rowspan="1" colspan="1">.148</td><td align="center" rowspan="1" colspan="1">.385</td><td align="center" rowspan="1" colspan="1">.120</td></tr><tr><td align="left" rowspan="2" colspan="1">LnHSI</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">0.006 (0.002, 0.010)</td><td align="center" rowspan="1" colspan="1">0.006 (0.000, 0.012)</td><td align="center" rowspan="1" colspan="1">0.005 (-0.001, 0.011)</td><td align="center" rowspan="1" colspan="1">0.006 (0.000, 0.013)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.004</td><td align="center" rowspan="1" colspan="1">.033</td><td align="center" rowspan="1" colspan="1">.120</td><td align="center" rowspan="1" colspan="1">.038</td><td align="center" rowspan="1" colspan="1">.087</td></tr><tr><td align="left" rowspan="2" colspan="1">LnFIB-4</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">0.011 (&#8208;0.011, 0.032)</td><td align="center" rowspan="1" colspan="1">0.023 (&#8208;0.005, 0.052)</td><td align="center" rowspan="1" colspan="1">0.001 (&#8208;0.033, 0.036)</td><td align="center" rowspan="1" colspan="1">&#8208;0.005 (&#8208;0.044, 0.033)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.337</td><td align="center" rowspan="1" colspan="1">.108</td><td align="center" rowspan="1" colspan="1">.935</td><td align="center" rowspan="1" colspan="1">.780</td><td align="center" rowspan="1" colspan="1">.541</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>Analyses were adjusted for age, gender, race, BMI, PIR, smoking, drinking, hypertension, diabetes, CHD.</p></fn><fn fn-type="other"><p>AKP = alkaline phosphatase, ALB = albumin, ALT = alanine aminotransferase, AST = aspartate aminotransferase, CHD = coronary heart disease, FIB-4 = fibrosis-4, GGT = gamma glutamyl transpeptidase, HSI = hepatic steatosis index, SA = sleep apnea, TP = total protein.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>3.3. Subgroup analyses</title><p>The forest plot of adjusted Beta and 95% confidence intervals in subgroups is presented in Figure <xref rid="F2" ref-type="fig">2</xref>. Subgroup analyses showed that the presence of SA was independently associated with lnALT, lnGGT, lnHSI, and lnAST/ALT in subgroup of BMI&#8197;&lt;&#8197;30&#8201;kg/m<sup>2</sup> (all <italic toggle="yes">P</italic> values&#8197;&lt;&#8197;.05). While in BMI&#8197;&#8805;&#8197;30, independent association only existed between SA and lnGGT. In subgroup of age&#8197;&lt;&#8197;50 years, SA was found to be independently linked to lnALT, lnAST, lnGGT, and lnHSI (all <italic toggle="yes">P</italic> values&#8197;&lt;&#8197;.05). However, no outcome parameter was showed to be independently correlated with SA (all <italic toggle="yes">P</italic> values&#8197;&#8805;&#8197;.05). SA was identified as having an independent association with lnAST/ALT, lnGGT, and lnHSI in male subjects (all <italic toggle="yes">P</italic> values&#8197;&lt;&#8197;.05). In female subjects, there is no observed outcome parameter associated with SA after adjusting confounders (all <italic toggle="yes">P</italic> values&#8197;&gt;&#8197;.05). In addition, we found that the association of SA and liver injury were more pronounced among non-Hispanic Black than other races (positive for lnALT, lnAST, lnAST/ALT, lnGGT, and lnHSI). The detailed information of results stratified by subgroups is further summarized in Tables S2, Supplemental Digital Content, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/MD/N418" ext-link-type="uri">http://links.lww.com/MD/N418</ext-link>, S3, Supplemental Digital Content, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/MD/N420" ext-link-type="uri">http://links.lww.com/MD/N420</ext-link>, S4, Supplemental Digital Content, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/MD/N421" ext-link-type="uri">http://links.lww.com/MD/N421</ext-link>, S5, Supplemental Digital Content, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/MD/N423" ext-link-type="uri">http://links.lww.com/MD/N423</ext-link>.</p><fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>Forest plots of beta coefficients (95% CI) of multivariable linear regression analyses between SA and liver injury in subgroups based on age, BMI, gender, and race. BMI = body mass index, CI = confidence interval, SA = sleep apnea.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="medi-103-e39393-g002.jpg"/></fig></sec><sec><title>3.4. Sensitivity analysis</title><p>Table <xref rid="T3" ref-type="table">3</xref> shows results of a sensitivity analysis that was conducted after imputing missing data for confounding variables. SA was significantly correlated with lnALT, lnAST/ALT, lnGGT, and lnHSI after adjusting confounders. A dose&#8211;response relationship between the severity of SA and lnALT, lnGGT, lnAST/ALT was noted. The results of analysis for imputed data were similar to the data without imputing missing values, which confirmed the robust results.</p><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><p>Results of weighted multivariate linear regression after imputing data for confounding variables.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="2">Outcomes</th><th align="center" rowspan="1" colspan="1">SA status</th><th align="center" colspan="4" rowspan="1">SA severity</th></tr><tr><th align="center" rowspan="1" colspan="1">SA</th><th align="center" rowspan="1" colspan="1">Rarely</th><th align="center" rowspan="1" colspan="1">Moderately</th><th align="center" rowspan="1" colspan="1">Frequently</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value for trend</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">LnALT</td><td align="center" rowspan="1" colspan="1">Adjusted <italic toggle="yes">&#946;</italic> (95% CI)</td><td align="center" rowspan="1" colspan="1">0.033 (0.013, 0.054)</td><td align="center" rowspan="1" colspan="1">0.031 (&#8208;0.000, 0.0628)</td><td align="center" rowspan="1" colspan="1">0.028 (&#8208;0.012, 0.069)</td><td align="center" rowspan="1" colspan="1">0.054 (0.022, 0.085)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.001</td><td align="center" rowspan="1" colspan="1">.068</td><td align="center" rowspan="1" colspan="1">.168</td><td align="center" rowspan="1" colspan="1">.001</td><td align="center" rowspan="1" colspan="1">.006</td></tr><tr><td align="left" rowspan="2" colspan="1">LnAST</td><td align="center" rowspan="1" colspan="1">Adjusted <italic toggle="yes">&#946;</italic> (95% CI)</td><td align="center" rowspan="1" colspan="1">0.007 (-0.007, 0.021)</td><td align="center" rowspan="1" colspan="1">0.004 (-0.015, 0.023)</td><td align="center" rowspan="1" colspan="1">0.003 (-0.024, 0.030)</td><td align="center" rowspan="1" colspan="1">0.017 (-0.014, 0.049)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.336</td><td align="center" rowspan="1" colspan="1">.674</td><td align="center" rowspan="1" colspan="1">.825</td><td align="center" rowspan="1" colspan="1">.279</td><td align="center" rowspan="1" colspan="1">.336</td></tr><tr><td align="left" rowspan="2" colspan="1">LnAST/ALT</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">-0.026 (-0.041, -0.012)</td><td align="center" rowspan="1" colspan="1">-0.023 (-0.044, -0.001)</td><td align="center" rowspan="1" colspan="1">-0.025 (-0.047, -0.003)</td><td align="center" rowspan="1" colspan="1">-0.036 (-0.057, -0.016)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">.037</td><td align="center" rowspan="1" colspan="1">.024</td><td align="center" rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">.003</td></tr><tr><td align="left" rowspan="2" colspan="1">lnGGT</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">0.058 (0.031, 0.085)</td><td align="center" rowspan="1" colspan="1">0.022 (-0.012, 0.057)</td><td align="center" rowspan="1" colspan="1">0.078 (0.025, 0.131)</td><td align="center" rowspan="1" colspan="1">0.112 (0.061, 0.162)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">.204</td><td align="center" rowspan="1" colspan="1">.005</td><td align="center" rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="2" colspan="1">LnAKP</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">&#8208;0.011 (&#8208;0.023, 0.001)</td><td align="center" rowspan="1" colspan="1">&#8208;0.008 (&#8208;0.025, 0.009)</td><td align="center" rowspan="1" colspan="1">&#8208;0.014 (&#8208;0.036, 0.007)</td><td align="center" rowspan="1" colspan="1">&#8208;0.012 (&#8208;0.034, 0.010)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.080</td><td align="center" rowspan="1" colspan="1">.334</td><td align="center" rowspan="1" colspan="1">.188</td><td align="center" rowspan="1" colspan="1">.283</td><td align="center" rowspan="1" colspan="1">.244</td></tr><tr><td align="left" rowspan="2" colspan="1">LnTP</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">&#8208;0.001 (&#8208;0.004, 0.002)</td><td align="center" rowspan="1" colspan="1">0.000 (&#8208;0.004, 0.003)</td><td align="center" rowspan="1" colspan="1">&#8208;0.002 (&#8208;0.006, 0.003)</td><td align="center" rowspan="1" colspan="1">&#8208;0.001 (&#8208;0.006, 0.003)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.499</td><td align="center" rowspan="1" colspan="1">.577</td><td align="center" rowspan="1" colspan="1">.443</td><td align="center" rowspan="1" colspan="1">.584</td><td align="center" rowspan="1" colspan="1">.477</td></tr><tr><td align="left" rowspan="2" colspan="1">LnALB</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">0.000 (&#8208;0.004, 0.003)</td><td align="center" rowspan="1" colspan="1">0.003 (&#8208;0.001, 0.008)</td><td align="center" rowspan="1" colspan="1">&#8208;0.005 (&#8208;0.011, 0.001)</td><td align="center" rowspan="1" colspan="1">&#8208;0.003 (&#8208;0.009, 0.003)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.827</td><td align="center" rowspan="1" colspan="1">.135</td><td align="center" rowspan="1" colspan="1">.118</td><td align="center" rowspan="1" colspan="1">.260</td><td align="center" rowspan="1" colspan="1">.069</td></tr><tr><td align="left" rowspan="2" colspan="1">LnHSI</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">0.006 (0.003, 0.010)</td><td align="center" rowspan="1" colspan="1">0.006 (0.001, 0.012)</td><td align="center" rowspan="1" colspan="1">0.006 (0.000, 0.012)</td><td align="center" rowspan="1" colspan="1">0.007 (0.001, 0.012)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">.014</td><td align="center" rowspan="1" colspan="1">.036</td><td align="center" rowspan="1" colspan="1">.026</td><td align="center" rowspan="1" colspan="1">.050</td></tr><tr><td align="left" rowspan="2" colspan="1">LnFIB-4</td><td align="center" rowspan="1" colspan="1">Adjusted &#946; (95% CI)</td><td align="center" rowspan="1" colspan="1">0.008 (&#8208;0.011, 0.027)</td><td align="center" rowspan="1" colspan="1">0.016 (&#8208;0.008, 0.040)</td><td align="center" rowspan="1" colspan="1">&#8208;0.002 (&#8208;0.033, 0.028)</td><td align="center" rowspan="1" colspan="1">0.001 (&#8208;0.030, 0.033)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="center" rowspan="1" colspan="1">.412</td><td align="center" rowspan="1" colspan="1">.190</td><td align="center" rowspan="1" colspan="1">.878</td><td align="center" rowspan="1" colspan="1">.934</td><td align="center" rowspan="1" colspan="1">.775</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>Analyses were adjusted for age, gender, race, BMI, PIR, smoking, drinking, hypertension, diabetes, CHD.</p></fn><fn fn-type="other"><p>AKP = alkaline phosphatase, ALB = albumin, ALT = alanine aminotransferase, AST = aspartate aminotransferase, CHD = coronary heart disease, FIB-4 = fibrosis-4, GGT = gamma glutamyl transpeptidase, HSI = hepatic steatosis index, SA = sleep apnea, TP = total protein.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>4. Discussion</title><p>The present study suggested that self-reported SA was independently associated with elevated liver enzymes and aggravated liver steatosis, but not with liver fibrosis. A dose&#8211;response relationship between severity of SA and elevated liver enzymes was also noted. Subgroup analyses revealed that the association of SA and liver injury was more pronounced among nonobese, younger, non-Hispanic Black, and male populations.</p><p>The relationship between OSA and liver injury has been investigated for many years. A study demonstrated an independent correlation between the severity of nocturnal hypoxia and the presence of steatosis assessed by noninvasive blood tests.<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> Trzepizur et al<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> studied 147 patients with metabolic comorbidities and found that severe OSA was associated with increased liver stiffness after controlling confounding factors. Another small-sample study focusing pediatric population showed significant correlations between OSA-related hypoxia and elevated transaminases, hepatic steatosis, NAFLD inflammation score, and liver fibrosis stage.<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> Despite the strong evidence supporting the impact of OSA on liver injury, some other studies have not found any association between them.<sup>[<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref>]</sup> Daltro et al<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup> conducted a study on 40 obese patients and revealed that OSA-related parameters did not show significant correlations with transaminases, liver histopathological characteristics, or nonalcoholic steatohepatitis.</p><p>Most studies only focused on obese patients in hospital and were limited by small sample size. Furthermore, the results remained controversial. Hence, this study with large sample size was performed based on community population. Our results supported an independent relationship between SA and elevated liver enzymes, aggravated liver steatosis. But this was not case for liver fibrosis. Consistent with the results of the present study, a multisite cross-sectional study with 1285 subjects evaluating OSA severity and blood markers of liver injury reported that OSA severity and sleep-related hypoxemia were independently associated with liver steatosis and liver cytolysis, but not with significant liver fibrosis.<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> In one of our previous studies, we included 160 consecutive patients suspected for OSA and identified that OSA severity was independently associated with liver steatosis and elevation of serum aminotransferases, but not with liver fibrosis.<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup> However, a meta-analysis showed that OSA was associated with increased risk of liver fibrosis independently of age, gender, and BMI.<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup> The discrepancy of results can be explained by the difference in the study samples. The majority of the studies included in the meta-analysis focused on morbidly obese patients undergoing bariatric surgery with intraoperative liver biopsies or patients with abnormal liver enzymes.</p><p>Several mechanisms contribute to the association between SA and elevated liver enzymes and aggravated liver steatosis. CIH triggers systemic inflammation, oxidative stress, and metabolic dysregulation, including insulin resistance and dyslipidemia.<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup> These factors lead to hepatic inflammation, lipid accumulation, and oxidative damage. Additionally, CIH induces endoplasmic reticulum stress and even liver cell ferroptosis.<sup>[<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>]</sup></p><p>Some clinical implications for the results could be highlighted. Based on the findings of the present study, it is suggested that it was necessary to closely monitor the liver injury for SA population, especially in nonobese, younger, non-Hispanic Black, and male subjects. In addition, some evidences have demonstrated a beneficial effect of OSA treatment on liver injury in adults<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup> and pediatric population.<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup> This emphasizes the significance of providing OSA treatments for these patients.</p><p>Subgroup analyses revealed that the links between SA and liver injury were more pronounced in nonobese, younger, non-Hispanic Black, and male population. In line with the results of the present study, we previously found that severe OSA was positively correlated with liver injury in males, while female OSA was not associated with liver injury in a group of Chinese Han population from the hospital.<sup>[<xref rid="R26" ref-type="bibr">26</xref>]</sup> Furthermore, another American study also found that the relationship between OSA and cardiovascular risk factors were stronger in male, younger individuals, and African American individuals.<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup> Similar to above results, Ghazi and coworkers<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup> reported high risk of OSA was correlated with prevalent atrial fibrillation among black people but not white people. These findings reflected differences in population susceptibility to OSA-related multiple organ injury. Further investigation of inter-individual differences in responses to OSA-related stressors or the genetic susceptibility may help identify targets for future interventions.</p><p>Our study possesses several notable strengths. Firstly, to the best of our knowledge, this study represents the largest sample size to date investigating the relationship between SA and liver injury. The large sample size allows us to establish a more robust conclusion. Secondly, this study used a community-based sample, thereby providing a better reflection of the general population compared to clinically-based studies. Thirdly, subgroup analyses were performed in this study, which provides insight into the variation in the relationship between OSA and liver injury across groups, assisting in the identification of the appropriate treatment population. Finally, the sensitivity analysis revealed that the conclusions remained robust even when subjected to methodological changes, indicating the reliability of the data in the present study.</p><p>Despite the strengths, some limitations should be considered. Firstly, the cross-sectional study design dose not allows us to establish causality between SA and liver injury. Secondly, the assessment of SA was solely based on self-reporting rather than objective indicators such as polysomnography. There may be both overestimation and underestimation of the true prevalence and severity of SA in our study population. However, self-reported data provide a feasible and cost-effective means for large-scale epidemiological studies. Our findings align with existing literature, further supporting the validity of our results. Thirdly, the diagnostic indices used in our study, namely the HSI and FIB-4, are not considered as the gold standards for diagnosing liver steatosis and liver fibrosis. However, previous studies have demonstrated a good performance of HSI and FIB-4 in diagnosing liver steatosis and liver fibrosis,<sup>[<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>]</sup> respectively. Finally, despite excluding participants with excessive alcohol intake, over 85% of the study population still drinks alcohol, which could potentially influence the results.</p><p>In conclusion, our findings indicated significant association between self-reported SA and elevated liver enzymes, aggravated liver steatosis among US population. The association was more pronounced among nonobese, younger, non-Hispanic black, and male subgroups. The results of our study suggested that it might be prudent to monitor the liver injury for people with SA.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Zhi-Wei Huang.</p><p><bold>Data curation:</bold> Yi-Bin Jiang.</p><p><bold>Formal analysis:</bold> Xue-Jun Lin, Li-Da Chen.</p><p><bold>Investigation:</bold> Yi-Bin Jiang, Zhi-Wei Huang.</p><p><bold>Methodology:</bold> Yi-Bin Jiang, Li-Da Chen.</p><p><bold>Project administration:</bold> Zhi-Wei Huang.</p><p><bold>Software:</bold> Jia-Min Luo.</p><p><bold>Writing &#8211; original draft:</bold> Yi-Bin Jiang.</p><p><bold>Writing &#8211; review &amp; editing:</bold> Zhi-Wei Huang, Li-Da Chen.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" id="s1" content-type="document" xlink:href="medi-103-e39393-s001.docx" position="anchor" orientation="portrait"/><media xmlns:xlink="http://www.w3.org/1999/xlink" id="s2" content-type="document" xlink:href="medi-103-e39393-s002.docx" position="anchor" orientation="portrait"/><media xmlns:xlink="http://www.w3.org/1999/xlink" id="s3" content-type="document" xlink:href="medi-103-e39393-s003.docx" position="anchor" orientation="portrait"/><media xmlns:xlink="http://www.w3.org/1999/xlink" id="s4" content-type="document" xlink:href="medi-103-e39393-s004.docx" position="anchor" orientation="portrait"/><media xmlns:xlink="http://www.w3.org/1999/xlink" id="s5" content-type="document" xlink:href="medi-103-e39393-s005.docx" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><fn-group><fn fn-type="abbr"><p>
<def-list><title>Abbreviations:</title><def-item><term>ALT</term><def><p>alanine aminotransferase</p></def></def-item><def-item><term>AST</term><def><p>aspartate aminotransferase</p></def></def-item><def-item><term>BMI</term><def><p>body mass index</p></def></def-item><def-item><term>CIH</term><def><p>chronic intermittent hypoxia</p></def></def-item><def-item><term>CHD</term><def><p>coronary heart disease</p></def></def-item><def-item><term>FIB-4</term><def><p>fibrosis-4</p></def></def-item><def-item><term>HSI</term><def><p>hepatic steatosis index</p></def></def-item><def-item><term>NAFLD</term><def><p>nonalcoholic fatty liver disease</p></def></def-item><def-item><term>NHANES</term><def><p>National Health and Nutrition Examination Survey</p></def></def-item><def-item><term>OSA</term><def><p>obstructive sleep apnea</p></def></def-item><def-item><term>PIR</term><def><p>family income-to-poverty ratio</p></def></def-item><def-item><term>SA</term><def><p>sleep apnea</p></def></def-item><def-item><term>TBIL</term><def><p>total bilirubin</p></def></def-item><def-item><term>TP</term><def><p>total protein</p></def></def-item></def-list>
</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>This research was funded by the Young People Training Project from Fujian Province Health Bureau (2022GGA053),</p></fn><fn fn-type="other"><p>The National Center for Health Statistics Research Ethics Review Board approved the NHANES protocol and all participants provided informed written consent.</p></fn><fn fn-type="COI-statement"><p>The authors have no conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>The datasets generated during and/or analyzed during the current study are publicly available.</p></fn><fn fn-type="supplementary-material"><p>Supplemental Digital Content is available for this article.</p></fn><fn fn-type="other"><p>How to cite this article: Jiang Y-B, Huang Z-W, Lin X-J, Luo J-M, Chen L-D. Association between self-reported sleep apnea and biomarkers of liver injury: Evidence from National Health and Nutrition Examination Survey. Medicine 2024;103:36(e39393).</p></fn><fn fn-type="equal"><p>Y-BJ and Z-WH contributed equally to this work.</p></fn></fn-group><ref-list id="r2"><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lisan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Marques-Vidal</surname><given-names>P</given-names></name><name name-style="western"><surname>Hausler</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease.</article-title><source>Sleep Med</source>. <year>2023</year>;<volume>109</volume>:<fpage>1</fpage>&#8211;<lpage>3</lpage>.<pub-id pub-id-type="pmid">37354730</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.sleep.2023.06.006</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reutrakul</surname><given-names>S</given-names></name><name name-style="western"><surname>Mokhlesi</surname><given-names>B</given-names></name></person-group>. <article-title>Obstructive sleep apnea and diabetes: a state of the art review.</article-title><source>Chest</source>. <year>2017</year>;<volume>152</volume>:<fpage>1070</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="pmid">28527878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2017.05.009</pub-id><pub-id pub-id-type="pmcid">PMC5812754</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Udholm</surname><given-names>N</given-names></name><name name-style="western"><surname>Rex</surname><given-names>CE</given-names></name><name name-style="western"><surname>Fuglsang</surname><given-names>M</given-names></name><name name-style="western"><surname>Lundbye-Christensen</surname><given-names>S</given-names></name><name name-style="western"><surname>Bille</surname><given-names>J</given-names></name><name name-style="western"><surname>Udholm</surname><given-names>S</given-names></name></person-group>. <article-title>Obstructive sleep apnea and road traffic accidents: a Danish nationwide cohort study.</article-title><source>Sleep Med</source>. <year>2022</year>;<volume>96</volume>:<fpage>64</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">35605348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.sleep.2022.04.003</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Senaratna</surname><given-names>CV</given-names></name><name name-style="western"><surname>Perret</surname><given-names>JL</given-names></name><name name-style="western"><surname>Lodge</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>Prevalence of obstructive sleep apnea in the general population: a systematic review.</article-title><source>Sleep Med Rev</source>. <year>2016</year>;<volume>34</volume>:<fpage>70</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="pmid">27568340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.smrv.2016.07.002</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Punjabi</surname><given-names>NM</given-names></name></person-group>. <article-title>The epidemiology of adult obstructive sleep apnea.</article-title><source>Proc Am Thorac Soc</source>. <year>2008</year>;<volume>5</volume>:<fpage>136</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="pmid">18250205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/pats.200709-155MG</pub-id><pub-id pub-id-type="pmcid">PMC2645248</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villaneuva</surname><given-names>AT</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>PR</given-names></name><name name-style="western"><surname>Yee</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Grunstein</surname><given-names>RR</given-names></name></person-group>. <article-title>Ethnicity and obstructive sleep apnoea.</article-title><source>Sleep Med Rev</source>. <year>2005</year>;<volume>9</volume>:<fpage>419</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">16183307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.smrv.2005.04.005</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mesarwi</surname><given-names>OA</given-names></name><name name-style="western"><surname>Loomba</surname><given-names>R</given-names></name><name name-style="western"><surname>Malhotra</surname><given-names>A</given-names></name></person-group>. <article-title>Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease.</article-title><source>Am J Respir Crit Care Med</source>. <year>2019</year>;<volume>199</volume>:<fpage>830</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="pmid">30422676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201806-1109TR</pub-id><pub-id pub-id-type="pmcid">PMC6835083</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mak</surname><given-names>JCW</given-names></name><name name-style="western"><surname>Ip</surname><given-names>MSM</given-names></name></person-group>. <article-title>Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease.</article-title><source>Sleep Med</source>. <year>2022</year>;<volume>95</volume>:<fpage>16</fpage>&#8211;<lpage>28</lpage>.<pub-id pub-id-type="pmid">35537279</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.sleep.2022.04.006</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>QC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LD</given-names></name><name name-style="western"><surname>Chen</surname><given-names>GP</given-names></name><etal/></person-group>. <article-title>Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease.</article-title><source>Sleep Breathing = Schlaf &amp; Atmung</source>. <year>2015</year>;<volume>19</volume>:<fpage>273</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="pmid">24870112</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11325-014-1008-7</pub-id><pub-id pub-id-type="pmcid">PMC4330463</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity.</article-title><source>Hepatology Int</source>. <year>2022</year>;<volume>16</volume>:<fpage>824</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12072-022-10347-2</pub-id><pub-id pub-id-type="pmid">35668285</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group>. <article-title>Organophosphate pesticide exposure and biomarkers of liver injury/liver function.</article-title><source>Liver Int</source>. <year>2022</year>;<volume>42</volume>:<fpage>2713</fpage>&#8211;<lpage>23</lpage>.<pub-id pub-id-type="pmid">36264137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/liv.15461</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Zou</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Association of sleep apnea and depressive symptoms among US adults: a cross-sectional study.</article-title><source>BMC Public Health</source>. <year>2023</year>;<volume>23</volume>:<fpage>427</fpage>.<pub-id pub-id-type="pmid">36879197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12889-023-15358-8</pub-id><pub-id pub-id-type="pmcid">PMC9987095</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trzepizur</surname><given-names>W</given-names></name><name name-style="western"><surname>Boursier</surname><given-names>J</given-names></name><name name-style="western"><surname>Mansour</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Association between severity of obstructive sleep apnea and blood markers of liver injury.</article-title><source>Clin Gastroenterol Hepatol</source>. <year>2016</year>;<volume>14</volume>:<fpage>1657</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="pmid">27155555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cgh.2016.04.037</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minville</surname><given-names>C</given-names></name><name name-style="western"><surname>Hilleret</surname><given-names>MN</given-names></name><name name-style="western"><surname>Tamisier</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.</article-title><source>Chest</source>. <year>2014</year>;<volume>145</volume>:<fpage>525</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">24264333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.13-0938</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trzepizur</surname><given-names>W</given-names></name><name name-style="western"><surname>Boursier</surname><given-names>J</given-names></name><name name-style="western"><surname>Le Vaillant</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities.</article-title><source>Eur Respir J</source>. <year>2018</year>;<volume>51</volume>:<fpage>1800601</fpage>.<pub-id pub-id-type="pmid">29880653</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.00601-2018</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundaram</surname><given-names>SS</given-names></name><name name-style="western"><surname>Sokol</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Capocelli</surname><given-names>KE</given-names></name><etal/></person-group>. <article-title>Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.</article-title><source>J Pediatr</source>. <year>2014</year>;<volume>164</volume>:<fpage>699</fpage>&#8211;<lpage>706.e1</lpage>.<pub-id pub-id-type="pmid">24321532</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpeds.2013.10.072</pub-id><pub-id pub-id-type="pmcid">PMC4014349</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daltro</surname><given-names>C</given-names></name><name name-style="western"><surname>Cotrim</surname><given-names>HP</given-names></name><name name-style="western"><surname>Alves</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?</article-title><source>Obes Surg</source>. <year>2010</year>;<volume>20</volume>:<fpage>1536</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="pmid">20556538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11695-010-0212-1</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>H</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>R</given-names></name><name name-style="western"><surname>Uhanova</surname><given-names>J</given-names></name><name name-style="western"><surname>Kryger</surname><given-names>M</given-names></name><name name-style="western"><surname>Hawkins</surname><given-names>K</given-names></name><name name-style="western"><surname>Minuk</surname><given-names>GY</given-names></name></person-group>. <article-title>Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.</article-title><source>Dig Dis Sci</source>. <year>2005</year>;<volume>50</volume>:<fpage>2338</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="pmid">16416185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10620-005-3058-y</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>LD</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Lin</surname><given-names>XJ</given-names></name><etal/></person-group>. <article-title>Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea.</article-title><source>Eur Arch Otorhinolaryngol</source>. <year>2018</year>;<volume>275</volume>:<fpage>587</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="pmid">29224042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00405-017-4840-0</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Musso</surname><given-names>G</given-names></name><name name-style="western"><surname>Cassader</surname><given-names>M</given-names></name><name name-style="western"><surname>Olivetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Rosina</surname><given-names>F</given-names></name><name name-style="western"><surname>Carbone</surname><given-names>G</given-names></name><name name-style="western"><surname>Gambino</surname><given-names>R</given-names></name></person-group>. <article-title>Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis.</article-title><source>Obesity Rev</source>. <year>2013</year>;<volume>14</volume>:<fpage>417</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/obr.12020</pub-id><pub-id pub-id-type="pmid">23387384</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirrakhimov</surname><given-names>AE</given-names></name><name name-style="western"><surname>Polotsky</surname><given-names>VY</given-names></name></person-group>. <article-title>Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?</article-title><source>Front Neurol</source>. <year>2012</year>;<volume>3</volume>:<fpage>149</fpage>.<pub-id pub-id-type="pmid">23087670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2012.00149</pub-id><pub-id pub-id-type="pmcid">PMC3473309</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Musso</surname><given-names>G</given-names></name><name name-style="western"><surname>Olivetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Cassader</surname><given-names>M</given-names></name><name name-style="western"><surname>Gambino</surname><given-names>R</given-names></name></person-group>. <article-title>Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms.</article-title><source>Semin Liver Dis</source>. <year>2012</year>;<volume>32</volume>:<fpage>49</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">22418888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0032-1306426</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>LD</given-names></name><name name-style="western"><surname>Wu</surname><given-names>RH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>YZ</given-names></name><etal/></person-group>. <article-title>The role of ferroptosis in chronic intermittent hypoxia-induced liver injury in rats.</article-title><source>Sleep Breathing = Schlaf &amp; Atmung</source>. <year>2020</year>;<volume>24</volume>:<fpage>1767</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="pmid">32361960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11325-020-02091-4</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>LD</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>Effect of continuous positive airway pressure on liver enzymes in obstructive sleep apnea: a meta-analysis.</article-title><source>Clin Resp J</source>. <year>2018</year>;<volume>12</volume>:<fpage>373</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/crj.12554</pub-id><pub-id pub-id-type="pmid">27614004</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundaram</surname><given-names>SS</given-names></name><name name-style="western"><surname>Halbower</surname><given-names>AC</given-names></name><name name-style="western"><surname>Klawitter</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Treating obstructive sleep apnea and chronic intermittent hypoxia improves the severity of nonalcoholic fatty liver disease in children.</article-title><source>J Pediatr</source>. <year>2018</year>;<volume>198</volume>:<fpage>67</fpage>&#8211;<lpage>75.e1</lpage>.<pub-id pub-id-type="pmid">29752170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpeds.2018.03.028</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>LD</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JF</given-names></name><name name-style="western"><surname>Chen</surname><given-names>GP</given-names></name><etal/></person-group>. <article-title>[Association and gender difference analysis of obstructive sleep apnea hypopnea syndrome and liver injury].</article-title><source>Zhonghua yi xue za zhi</source>. <year>2022</year>;<volume>102</volume>:<fpage>550</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="pmid">35196776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3760/cma.j.cn112137-20210617-01371</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geovanini</surname><given-names>GR</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Weng</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Association between obstructive sleep apnea and cardiovascular risk factors: variation by age, sex, and race. the multi-ethnic study of atherosclerosis.</article-title><source>Ann Am Thor Soc</source>. <year>2018</year>;<volume>15</volume>:<fpage>970</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201802-121OC</pub-id><pub-id pub-id-type="pmcid">PMC6322035</pub-id><pub-id pub-id-type="pmid">29742365</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghazi</surname><given-names>L</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>A</given-names></name><name name-style="western"><surname>Petrov</surname><given-names>ME</given-names></name><etal/></person-group>. <article-title>Race, sex, age, and regional differences in the association of obstructive sleep apnea with atrial fibrillation: reasons for geographic and racial differences in stroke study.</article-title><source>J Clin Sleep Med</source>. <year>2018</year>;<volume>14</volume>:<fpage>1485</fpage>&#8211;<lpage>93</lpage>.<pub-id pub-id-type="pmid">30176963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5664/jcsm.7320</pub-id><pub-id pub-id-type="pmcid">PMC6134254</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>XL</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>LS</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CS</given-names></name><etal/></person-group>. <article-title>The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: a diagnostic or screening tool?</article-title><source>J Formosan Med Assoc = Taiwan yi zhi</source>. <year>2022</year>;<volume>121</volume>:<fpage>454</fpage>&#8211;<lpage>66</lpage>.<pub-id pub-id-type="pmid">34325952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jfma.2021.07.013</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.</article-title><source>Digest Liver Dis</source>. <year>2010</year>;<volume>42</volume>:<fpage>503</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dld.2009.08.002</pub-id><pub-id pub-id-type="pmid">19766548</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>